A director at one of the top clinical-stage biotech companies sold 6,000 insider shares towards the end of January 2026 amid ...

These two EV stocks are hot topics in the automotive industry, but only one is a buy for risk-tolerant investors.

Rising adoption of generative AI models from OpenAI and Anthropic directly affects the major cloud computing platforms.

One of the top executives at a leading cloud software company exercised options in mid-January 2026, resulting in the sale of ...

ASML is the sole provider of extreme ultraviolet (EUV) lithography machines. And you need an EUV lithography machine if you ...

Better still, Nvidia's stock seems rather appealingly priced. It has a recent forward-looking price-to-earnings (P/E) ratio ...

This ETF targets a diversified mix of investment grade bonds, aiming to deliver stable income and total return for investors.

Maybe it's time for the business to open itself up as a buyout target. Assuming there's a 25% premium, Peloton would cost a ...

Like Meta, Amazon remains reasonably priced. The stock looks like a bargain today, trading for 30x forward earnings estimates ...

The biggest driver of BigBear.ai's poor financial performance is its reliance on government contracts for the majority of its revenue, as the company noted in its quarterly filing. So, changes in ...

This leveraged ETF seeks to amplify daily returns of Alphabet Inc. through swap agreements, targeting investors with bullish ...

This bioscience company has had promising financials, yet one of its top executives exited her entire direct equity ownership in mid-January 2026.